Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125560813 | 12556081 | 3 | F | 20160108 | 20160816 | 20160714 | 20160829 | EXP | MX-BAYER-2016-014011 | BAYER | 43.00 | YR | A | F | Y | 70.00000 | KG | 20160829 | CN | MX | MX |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125560813 | 12556081 | 1 | PS | BETAFERON | INTERFERON BETA-1B | 1 | Subcutaneous | 1 DF, QOD | 103471 | 1 | DF | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | QOD | ||||||
| 125560813 | 12556081 | 2 | SS | BETAFERON | INTERFERON BETA-1B | 1 | Subcutaneous | 1 DF, TIW | 103471 | 1 | DF | POWDER AND SOLVENT FOR SOLUTION FOR INJECTION | TIW | ||||||
| 125560813 | 12556081 | 3 | SS | Salbutamol | ALBUTEROL | 1 | 1 DF, BID | 0 | 1 | DF | BID | ||||||||
| 125560813 | 12556081 | 4 | SS | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | 2 DF, Q8HR | 0 | 2 | DF | Q8H | ||||||||
| 125560813 | 12556081 | 5 | C | DIGOXIN. | DIGOXIN | 1 | 0.5 DF, QD | 0 | .5 | DF | QD | ||||||||
| 125560813 | 12556081 | 6 | C | Isorbid | 2 | 10 MG, QD | 0 | 10 | MG | QD | |||||||||
| 125560813 | 12556081 | 7 | C | KETOROLAC | KETOROLACKETOROLAC TROMETHAMINE | 1 | UNK | 0 | |||||||||||
| 125560813 | 12556081 | 8 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 1 DF, BID | 0 | 1 | DF | BID | ||||||||
| 125560813 | 12556081 | 9 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 2 DF, QD | 0 | 2 | DF | QD | ||||||||
| 125560813 | 12556081 | 10 | C | Novotiral | LEVOTHYROXINE | 1 | 1 DF, QD | 0 | 1 | DF | QD | ||||||||
| 125560813 | 12556081 | 11 | C | atorvastatin | ATORVASTATIN | 1 | 1 DF, QD | 0 | 1 | DF | QD | ||||||||
| 125560813 | 12556081 | 12 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 1 DF, QD | 0 | 1 | DF | QD | ||||||||
| 125560813 | 12556081 | 13 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | 1 DF, BID | 0 | 1 | DF | BID | ||||||||
| 125560813 | 12556081 | 14 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | 10 MG, QD | 0 | 10 | MG | QD | ||||||||
| 125560813 | 12556081 | 15 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | UNK | 0 | QD | ||||||||||
| 125560813 | 12556081 | 16 | C | LASIX | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 125560813 | 12556081 | 17 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 125560813 | 12556081 | 18 | C | LOSARTAN. | LOSARTAN | 1 | 1 DF, QD | 0 | 1 | DF | QD | ||||||||
| 125560813 | 12556081 | 19 | C | METOPROLOL. | METOPROLOL | 1 | 0.500 DF, BID | 0 | .5 | DF | BID | ||||||||
| 125560813 | 12556081 | 20 | C | ISOSORBIDE. | ISOSORBIDE | 1 | 1 DF, BID | 0 | 1 | DF | BID | ||||||||
| 125560813 | 12556081 | 21 | C | FUROSEMIDE. | FUROSEMIDE | 1 | 1 DF, BID | 0 | 1 | DF | BID | ||||||||
| 125560813 | 12556081 | 22 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | 1 DF, BID | 0 | 1 | DF | BID | ||||||||
| 125560813 | 12556081 | 23 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 1 DF, QD | 0 | 1 | DF | QD | ||||||||
| 125560813 | 12556081 | 24 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 1 DF, QD | 0 | 1 | DF | QD | ||||||||
| 125560813 | 12556081 | 25 | C | SENNOSIDE | SENNOSIDES | 1 | 3 DF, QD | 0 | 3 | DF | QD | ||||||||
| 125560813 | 12556081 | 26 | SS | INTERFERON BETA-1B [INTERFERON BETA-1B] | INTERFERON BETA-1B | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125560813 | 12556081 | 1 | Multiple sclerosis |
| 125560813 | 12556081 | 2 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125560813 | 12556081 | OT |
| 125560813 | 12556081 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125560813 | 12556081 | Amnesia | |
| 125560813 | 12556081 | Arthralgia | |
| 125560813 | 12556081 | Asphyxia | |
| 125560813 | 12556081 | Asthenia | |
| 125560813 | 12556081 | Blood creatinine increased | |
| 125560813 | 12556081 | Blood pressure decreased | |
| 125560813 | 12556081 | Chest pain | |
| 125560813 | 12556081 | Chills | |
| 125560813 | 12556081 | Constipation | |
| 125560813 | 12556081 | Dry mouth | |
| 125560813 | 12556081 | Dyspnoea | |
| 125560813 | 12556081 | Erythema of eyelid | |
| 125560813 | 12556081 | Eyelid oedema | |
| 125560813 | 12556081 | Feeling abnormal | |
| 125560813 | 12556081 | Feeling of despair | |
| 125560813 | 12556081 | Haemoglobin decreased | |
| 125560813 | 12556081 | Headache | |
| 125560813 | 12556081 | Hepatic steatosis | |
| 125560813 | 12556081 | Liver disorder | |
| 125560813 | 12556081 | Mobility decreased | |
| 125560813 | 12556081 | Pallor | |
| 125560813 | 12556081 | Product use issue | |
| 125560813 | 12556081 | Renal disorder | |
| 125560813 | 12556081 | Tongue oedema |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125560813 | 12556081 | 1 | 20160104 | 201601 | 0 | |
| 125560813 | 12556081 | 2 | 20160108 | 201605 | 0 |